Medtronic plc (NYSE: MDT), a leading global healthcare technology company, stands out as a compelling option. It offers a distinctive combination of defensive traits and growth opportunities ...

The Eluvia drug-eluting stent. [Image courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD.